Literature DB >> 30226969

BARTH SYNDROME IN MALE AND FEMALE SIBLINGS CAUSED BY A NOVEL MUTATION IN THE TAZ GENE.

D M Avdjieva-Tzavella, A P Todorova, M B Ivanova, I T Yordanova, T P Todorov, I O Litvinenko, A T Dasheva-Dimitrova, R S Tincheva.   

Abstract

Barth syndrome (BTHS) is an X-linked recessive disease caused by mutations in tafazzin gene (TAZ) which lead to cardiolipin deficiency and mitochondrial dysfunction. Male patients have variable clinical findings, including cardiomyopathy, skeletal myopathy, prepubertal short stature, neutropenia and 3-methylglutaconic aciduria. Female carriers are usually asymptomatic. We report a novel TAZ gene mutation in male and female siblings with left ventricular noncompaction and hypotonia. Additionally, the brother presented an intermittent neutropenia and increased urinary levels of 3-methylglutaconic and 3-methylglutaric acid. The molecular genetic testing showed that both siblings carry the mutation: c.253insC, p.(Arg85Profs*54) in exon 3 of the TAZ gene. This article presents the first case of BTHS in a heterozygous female patient with normal karyotype.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 30226969

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  3 in total

Review 1.  Role of Tafazzin in Mitochondrial Function, Development and Disease.

Authors:  Michael T Chin; Simon J Conway
Journal:  J Dev Biol       Date:  2020-05-23

2.  Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome.

Authors:  Brittany Hornby; William Reid Thompson; Mohammed Almuqbil; Ryan Manuel; Anthony Abbruscato; Jim Carr; Hilary J Vernon
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

3.  An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.

Authors:  Frédéric M Vaz; Henk van Lenthe; Martin A T Vervaart; Femke S Stet; Johanne H Klinkspoor; Hilary J Vernon; Susan M I Goorden; Riekelt H Houtkooper; Willem Kulik; Ronald J A Wanders
Journal:  J Inherit Metab Dis       Date:  2021-08-24       Impact factor: 4.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.